Research and Development

Research and Development

• Biomedical Research@
• Consulting@
• Contract Research@

Research and Development Links

• Equi-Tox, Inc. Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine.
  
• Perry Scientific, Inc. A full service contract research organization, a member of AALAS following AAALAC and NIH guidelines. We can supply all the services you need for drug development; from in vitro screening through preclinical animal studies to low cost preliminary clinical trials coordinated and performed offshore.
  
• Centocor Inc. Pharmaceutical company makes Remicade, new treatment for Crohn's Disease.
  
• Maelor Pharmaceuticals, Ltd. Development and licencing out of novel presentations of off-patent generic pharmaceuticals and medical devices. Specialising in the fields of urology, intravenous fluids, woundcare and anaesthesia in plastic and flexible delivery systems.
  
• Maas BiolAB LLC Developing treatments for CNS disease.
  
• MDS Panlabs Provides pharmacology, lead discovery, HTS, metabolism, drug discovery, drug development, safety pharmacology, biotechnology, and biosafety contract research services.
  
• Applied Genetics Inc., Dermatics A private biopharmaceutical company focusing on DNA repair technology, dermatology, liposome diagnosis, skin cancer research and early cancer diagnosis and the lifestyle enhancement market.
  
• ICAgen, Inc. Discovers and develops pharmaceutical products to treat medical conditions such as atrial fibrillation, urinary incontinence, central nervous system disorders, and sickle cell disease.
  
• APEX International Clinical Research Co., Ltd. (CRO) An Asia-Pacific based, ICH-GCP compliant CRO offering a complete range of Clinical Research and New Drug Development Services.
  
• Biota Holdings, Ltd. Biota is an Australian listed company, based in Melbourne and engaged in the management of research and development of human pharmaceuticals for the treatment of viral respiratory diseases.
  
• NanoPharm AG Develops novel carrier systems for the treatment of brain tumors and nervous system disorders using biodegradable nanoparticles. Nanosphere drug targeting systems allow any drug to cross the blood-brain barrier.
  
• Metabolic Solutions, Inc. Services in support of Erythromycin Breath Test and mass spectrometry service for measuring stable isotopes.
  
• Pharmacopeia Online Provider of products and services that accelerate drug discovery and chemical development.
  
• iO Pharmaceuticals Drug development solutions for the pharmaceutical and biotechnology industries.
  
• PanTherix Ltd Using leading technologies in structural enzymology to discover and develop drugs for fighting infectious diseases.
  
• Porphyrin Systems Research and development and production of new porphyrinic photosensitizers for photodynamic cancer therapy and other applications in collaboration with partners from institutes and universities throughout Europe.
  
• Gilead Sciences, Inc. A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia.
  
• Diagnos-Techs, Inc. - Clinical and Research Laboratory Originators of clinical saliva testing for female and male hormones.
  
• MDL Information Systems, Inc. MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and development in the life sciences and chemical industries.
  
• SERAF Therapeutics, Inc. Early stage pharmaceutical company specializing in targeted delivery of therapeutic componds to specific immune cells as cost-effective therapy for inflammatory & autoimmune diseases.
  
• Strathclyde Institute for Drug Research Early stage drug discovery opportunities, research expertise and facilities, and intellectual property available for licensing from the Strathclyde Institute for Drug Research, University of Strathclyde, Glasgow, Scotland.
  
• Dr. J.R.K's Siddha Research & Pharmaceuticals Pvt. Ltd. Indian Pharmaceutical company manufacturing, marketing effective & safe herbal products for PSORIASIS, VITILIGO and any other skin aliments.
  
• Oxford GlycoSciences - Corporate An established proteomics-based drug discovery company founded by Oxford University to identify and analyse glycoproteins. OGS is today recognised as a world leader in proteomic technology and pharmaceutical glycobiology R&D.
  
• Virginia Mason Research Center & Diabetes Research The new Benaroya Research Institute at Virginia Mason is a state-of-the-art facility built specifically for collaborative biomedical research.
  
• Cranial Pain Research A southwestern United States investigative site for pharmaceutical research studies, and a leader in dental pain studies for the past 11 years.
  
• ProCertus BioPharm, Inc. Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals and humans against lethal gastrointestinal pathogens and carcinogens.
  
• Biotron, Ltd. Australian biomedical research company, which funds, manages, and commercialises diagnostic and therapeutic research projects including cancer diagnostic tests and antiviral agents.
  
• Isis Pharmaceuticals, Inc. Biomedical pharmaceutical company working on new treatments for Crohn's Disease.
  
• Integrated Biologics Research Laboratories The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease.
  
• SynX Pharma Inc. SYNX Pharma Inc. aims to be a leader in the discovery and development of diagnostics and business opportunities for applications in preventative medicine and disease management.
  
• IVS Technologies, L.L.C. Homepage RUO kits for molecular diagnosis of leukemias, lymphomas and other neoplasms. TSO service for identification of leukemias and lymphomas. Proprietary technologies for in vivo cDNA synthesis and molecular diagnostics.
  
• Coley Pharmaceutical Group (CPG) Developing innovative therapeutic and prophylactic products that harness the power of the immune system to treat cancer, allergy, asthma and infectious diseases, and help accelerate recovery of the immune system after cancer chemotherapies.
  
• Signature BioScience, Inc. Signature BioScience is the world leader in PhenoDynamic Profiling for pharmaceutical discovery and development. Using proprietary bioassay systems and bioinformatics databases to characterize cellular and molecular interactions in complex biological systems.
  
• CRID Pharma Health Products Development Pharmaceutical development, clinical research, investigational drug products, clinical trials, MA, development strategy.
  
• TriStar Enterprises, Inc. Organized to deliver new technology and pharmaceutical discoveries to the marketplace to improve healthcare.
  
• Alisis Pharma, Ltd. Oxford-based drug discovery company focused on the identification of small molecule therapeutics for the treatment of cancer and infectious disease.
  
• CoPharma, Inc. Pharmaceutical company specifically focused on drug development by forming joint ventures with discovery-based companies.
  
• Access Pharmaceuticals A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term major product opportunities.
  
• Paragon BioServices, Inc. A contract research organization providing products and research services in molecular biology, cell culture, biochemistry, and molecular histology to accelerate each client's drug discovery and preclinical development efforts.
  
• BioGenysis "Health care solutions for the next millennium"
  
• Verne Mendel Medical Corporation Developing cause-oriented treatment for Parkinson's, Alzheimers, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine.
  
• Health Arising RxIBR is bringing innovations, Targeted Biologic Therapy from the Institute of Biologic Research into commercial fruition.
  
• First-Pass Web-based tool that outlines a preclinical development plan that is comprehensive in its content and its consideration of issues that impact planning budgets and timelines.
  
• Ichor Medical Systems, Inc. Developing platform electroporation technology for targeted in vivo delivery of membrane limited therapeutic agents including pharmaceutical compounds and DNA-based therapies.
  
• Tuberculosis Research Centre Established in 1956 under the auspices of the Indian Council of Medical Research, the World Health Organisation and the British Medical Research Council, for obtaining unimpeachable information on the feasibility,efficacy and safety of domiciliary treatment for pulmonary tuberculosis.
  
• Key Oncologics (Pty) Ltd, South Africa Biopharmaceutical company with a focus on marketing anticancer pharmaceuticals, and conducting oncology clinical trials.
  
• Serono Pharmaceutical Research Institute (SPRI) A unique biotech leader, Swiss developer of pharmaceutical products.
  
• Center for Drug Chemistry Russian research Center aimed at creation of original medicinal preparations for prevention and treatment of cardiovascular, nervous and mental diseases and viral, bacterial and fungus infections.
  
• Prescription Dispensing Laboratories Compounding and research pharmacy with a focus in drug delivery systems, primarily in the topical therapeutic application of drugs. PDL has developed several new compounds for the management of pain and nausea, especially for the terminally ill hospice patient.
  
• EUCRO European Contract Research GmbH & Co.KG EUCRO - aims to supply companies with new product opportunities through own product development or co-development, globalisation of licences and trading of health care products.
  
• Destiny Pharma, Ltd. Pharmaceutical company specialised in photodynamic therapy (PDT). Destiny has a custom research service specialised in formulations, in phospholipids, liposomes and other solubilisation and suspension systems.
  
• Rentschler Biotechnology Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards.
  
• Palumed S.A. Pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum.
  
• Institut de Recherche Jouveinal / Parke-Davis A leading centre in Europe for pharmaceutical R&D is specialised in inflammation, gastroenterology, pain, and the cardiovascular and nervous systems.
  
• Cytopia Pty, Ltd. Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, inter alia. Cytopia's first molecular targets are members of the JAK family of protein tyrosine kinases.
  
• SLIL Biomedical Corp A biopharmaceutical company discovering and developing new drugs to fight cancer.
  
• Discovery Partners International Provider of technology, products and services that augment the drug discovery efforts of the pharmaceutical industry.
  
• Centre for Photobiology and Photodynamic Therapy The Leeds centre brings together more than 40 experts in biochemistry, chemistry, physics, biomedical science and clinical medicine to develop the new technology known as 'Photodynamics'.
  
• Procyon BioPharma Inc. A Montreal-based cancer therapeutics company focused on advancing several platform technologies that have potential to treat, diagnose and prevent cancer.
  
• Oncopharm Corporation Involved in research, development and production of new antileukemic drugs.
  
• Genome Therapeutics Corporation Building pathways to the next generation of pharmaceuticals based on rational insights into the fundamental mechanisms of disease.
  
• Pharmadigm, Inc. Pharmadigm is developing a new class of anti-inflammatory agent useful in the management of acute inflammatory responses associated with burns, asthma, major trauma, heart attack, & stroke.
  
• Speedel Pharma Speedel's business objective is to acquire/in-license and develop innovative molecules through fast-track drug development and innovative technical problem solving in the drug development process.
  
• Karo Bio AB A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
  
• Hauser Laboratories A high quality research, development and testing laboratories offering a broad range of services to all phases of the pharmaceutical industry from early drug development through commercial manufacturing.
  
• Mercodia Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
  
• Reddy US Therapeutics, Inc. Biopharmaceutical company located in Atlanta, Georgia. It is a subsidiary of Dr. Reddys Group, Hyderabad, India. Our research focus is on discovering novel therapeutics that address unmet medical needs in diabetes, inflammation, lipid metabolism, oncology and cardiovascular disease.
  
• Repair, Inc. Biopharmaceutical company developing sustained release angiogenesis therapies to repair diseased organs and tissues. The company is initially developing products to treat coronary artery disease by stimulating the growth of new blood vessels in the oxygen starved heart muscle.
  
• PRA International Drug Development PRA International is the world's largest privately-held clinical Contract Research Organization. Through fully integrated operations in the US and Europe, PRA designs and implements clinical development programs worldwide.
  
• Chauvin European Group in Ophthalmology and Eye Surgery Research and development pharmaceutical company in ophthalmology marketing prescription products, ophthalmological surgery and OTC products.
  
• Arrow Therapeutics UK company dedicated to the discovery of novel drug candidates in the anti-infective area.
  
• MDS Pharma Services Global contract research organization, offering a complete spectrum of services in drug discovery and development. Our capabilities span from the earliest stages of research through Phase IV, including bioanalytical and central laboratory services.
  
• Steroidogenesis Inhibitors International The world leader in the treatment of elevated cortisol related diseases.
  
• Chauvin Group Chauvin European research and development pharmaceutical company specializing in ophthalmology with three activities: prescription products, ophthalmological surgery and OTC products.
  
• Neurotech Co., Ltd. Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances.
  
• Vasculogenix, Inc. Biopharmaceutical company dedicated to the discovery and commercialization of therapeutic agents that target blood vessel formation.
  
• Myriad Genetics Inc. Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testing.
  
• NeoTherapeutics, Inc. Leading R&D BioPharmaceutical company focusing on Neurodegenerative conditions such as Alzheimer's Disease, Parkinsons Disease, Spinal Cord Injury, Stroke and others.
  
• WITA Proteomics Focuses on the high resolution separation and identification of proteins from human tissue and analysis to describe differences between diseased and normal states for rapid drug discovery.
  
• Eli Lilly Pharmaceutical Eli Lilly Ireland, specialising in women's health, depression and schizophrenia.
  
• Pharmaceutics International, Inc. Formulation development - Formed in 1994, PII is a customer orientated company committed to producing a quality on time service. Our core business is formulation development together with Clinical Trial Material manufacturing and commercial manufacture of low volume products.
  
• InterMune Pharmaceuticals Develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders.
  
• The Degge Group, Ltd. Our mission is to optimize the therapy and prevention of disease in populations in the US and abroad through regulatory support, innovative epidemiological research, education, and product development.
  
• Calcigen Corporation A privately-held company producing high-purity actives and intermediaries for the pharmaceutical and biotechnology industries. Calcigen Corporation is also engaged in research and development of novel therapeutics and drug delivery mechanisms.
  
• CNS Healthcare - Clinical Neuroscience Solutions Advanced evaluations, treatments, monitoring, education, for those with psychiatric and neurological diseases.
  
• AlteonPharma Development of pharmaceutical products for the complications of diabetes and age-related diseases.
  
• Berlex Laboratories, Inc. Specializes in diagnostic imaging, female healthcare and therapeutics for treatment of life-threatening and disabling diseases.
  
• Cambridge Drug Discovery Innovative biological solutions for discovery in pharmaceutical, agrochemical and biotechnology industries.
  
• UCB Pharma Pharmaceutical subsidiary of UCB Group. Activities are focused on development of drugs for treatment of disorders of neurovascular or allergic origin -- particularly nootropics and one of its leading molecules, cetirizine.
  
• Calydon Developing pharmaceuticals for the treatment of cancer.
  
• CCM Pharma Focus on special drug delivery system and novel dosage form development has resulted in the launch of its blockbuster product Omesec® capsule.
  
• Cytochroma, Inc. Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located in Kingston, Ontario, Canada.
  
• Argenta Discovery Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series.
  
• Collagenex Pharmaceuticals Discovering, developing and commercializing new therapeutic agents.
  
• GloboMax LLC Pharmaceutical CRO and PDO based in Hanover, MD with worldwide affiliate companies.
  
• Chiroscience Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines for improved healthcare.
  
• Arachnova, Ltd. Virtual pharmaceutical discovery and development company. Specialists in outsourced project and technology management.
  
• Conpharm An independent pharmaceutical company headquartered in Uppsala, Sweden. The company develops and markets, through licensees, pharmaceutical products based on substances extracted from the Podophyllum plant.
  
• Institute for Diabetes Discovery Research company and institute dedicated to the discovery of novel drugs and therapeutics for diabetes, its complications, obesity, and related disorders.
  
• Vista Biologicals Corporation Production of animal cells, cell-derived products, & related contract research for the chemical, pharmaceutical, & biotechnology industries; such as production & purification of monoclonal antibodies or recombinant products from animal or insect cell expression systems.
  
• Bilaurand Laboratories, Ltd. A high-tech company specialising in research, development, manufacturing, licensing and marketing of pet and human healthcare products.
  
• Pherin Pharmaceutical Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders.
  
• Cerep Provides services in pharmacology, in molecular biology and lead development, in toxicology, metabolism and bio-availability, in combinatorial chemistry, HTS, HTP, HTLD and computational chemistry.
  
• BioStratum, Inc. Outlines the company's lead drug candidates, technology and research. Also includes news of the company's latest developments in the field of basal lamina technology and target diseases.
  
• Mycota Biosciences, Inc. Research and development focus in integrated target identification and drug discovery.
  
• Genentech, Inc. Genentechs mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day.
  
• Inveresk Research A contract research laboratory which offers a complete range of preclinical services and conduct clinical studies from Phase I to Phase IV.
  
• Corporate Technology Development, Inc. CTD is a specialty pharmaceutical and drug development company that develops and commercializes proprietary new uses and applications for pharmaceutical chemical entities approved by the US FDA.